Impact of T Lymphocytes Isolated from Liver Perfusate of Deceased Brain Donors on Kidney Transplantation: Preliminary Evidence and Future Directions
暂无分享,去创建一个
Giovanni Zito | P. Conaldi | G. Amico | D. Pagano | F. di Francesco | S. Gruttadauria | Caterina Accardo | S. Li Petri | P. Bonsignore | A. Tropea | S. Calamia | I. Vella | R. Busà | E. Badami | P. Salis | B. Buscemi | Salvatore Piazza
[1] E. Rhee. Kidney-specific metabolomic profiling in machine perfusate. , 2023, Kidney international.
[2] H. Cardinal,et al. Hypothermic Perfusion Modifies the Association Between Anti-LG3 Antibodies and Delayed Graft Function in Kidney Recipients , 2023, Transplant International.
[3] C. Niemann,et al. Hypothermia or Machine Perfusion in Kidney Donors. , 2023, The New England journal of medicine.
[4] M. Bellini,et al. Organ Reconditioning and Machine Perfusion in Transplantation , 2023, Transplant International.
[5] Z. Moon,et al. Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial , 2023, EClinicalMedicine.
[6] Martijn P. D. Haring,et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. , 2023, Journal of hepatology.
[7] P. Reese,et al. Untargeted metabolomics of perfusate and their Association with pump perfusion and allograft failure. , 2022, Kidney international.
[8] S. Parajuli,et al. Delayed graft function: current status and future directions , 2022 .
[9] A. Mehrabi,et al. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial , 2022, BMJ Open.
[10] U. Sack,et al. The Role of Innate Immune Cells in the Prediction of Early Renal Allograft Injury Following Kidney Transplantation , 2022, Journal of clinical medicine.
[11] Maria Rita Gulotta,et al. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection , 2022, Viruses.
[12] K. Asehnoune,et al. Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME) , 2022, BMJ Open.
[13] I. Mucsi,et al. Normothermic Ex Vivo Kidney Perfusion for Human Kidney Transplantation: First North American Results , 2022, Transplantation.
[14] A. Gallo,et al. Human Amnion-Derived Mesenchymal Stromal/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia/Reperfusion , 2022, Cells.
[15] A. Rajab,et al. Machine perfusion of kidney allografts affects early but not late graft function. , 2021, American journal of surgery.
[16] S. Serni,et al. Delayed graft function and perfusion parameters of kidneys from uncontrolled donors after circulatory death , 2020, Perfusion.
[17] J. Hoheisel,et al. Phase-I trial of donor-derived modified immune cell infusion in kidney transplantation. , 2020, The Journal of clinical investigation.
[18] R. Liotta,et al. Crucial Role of Extended Criteria Donors in Deceased Donor Single Kidney Transplantation to Face Chronic Shortage in the Heart of the Mediterranean Basin: A Single-Center Experience. , 2019, Transplantation proceedings.
[19] F. Claas,et al. Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies , 2019, Scientific Reports.
[20] R. Liotta,et al. Liver Perfusate Natural Killer Cells From Deceased Brain Donors and Association With Acute Cellular Rejection After Liver Transplantation: A Time-to-Rejection Analysis , 2019, Transplantation.
[21] David W. Johnson,et al. Association Between Duration of Delayed Graft Function, Acute Rejection, and Allograft Outcome After Deceased Donor Kidney Transplantation , 2019, Transplantation.
[22] D. Bumann,et al. Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti‐Pathogen Immunity , 2019, Immunity.
[23] Alessandro Nanni Costa,et al. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[24] R. Lechler,et al. T-cell alloimmunity and chronic allograft dysfunction. , 2010, Kidney international. Supplement.
[25] G. Pietrosi,et al. Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. , 2009, World journal of gastroenterology.
[26] G. Pietrosi,et al. Clinical applications of hepatocyte transplantation. , 2009, World journal of gastroenterology.
[27] E. Engleman,et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. , 2008, The New England journal of medicine.
[28] W. Weimar,et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. , 2000, Transplantation.
[29] N. Perico,et al. Peripheral donor leukocytes prolong survival of rat renal allografts. , 1999, Kidney international.
[30] B. Griffith,et al. Infusion of donor leukocytes to induce tolerance in organ allograft recipients , 1999, Journal of leukocyte biology.